Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesThe use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS
Journal of Affective Disorders, 06/22/09
Kelly T et al. - A high percentage of bipolar II and bipolar NOS patients with treatment resistant depression improved on T3. Despite the use of higher than usual doses in many of the patients, the medication was well tolerated. Augmentation with supraphysiologic doses of T3 should be considered in cases of treatment resistant bipolar depression.
Methods- Retrospective chart review of patients treated in a private clinic between 2002 and 2006.
- The charts of 125 patients with bipolar II disorder and 34 patients with bipolar disorder NOS were reviewed.
- Patients had been unsuccessfully treated with an average of 14 other medications before starting T3.
- At an average dose of 90.4 mcg (range 13 mcg–188 mcg) the medication was well tolerated.
- None of the patients experienced a switch into hypomania, and only 16 discontinued due to side effects.
- Improvement was experienced by 84%, and 33% experienced full remission.
Related Articles
Safety and Efficacy of Quetiapine in Bipolar Depression
Annals of Pharmacotherapy, 10/13/09
Relevance Score: 67%
Mecamylamine ? a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Expert Opinion in Pharmacotherapy, 11/02/09
Relevance Score: 64%
Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09
Relevance Score: 46%
Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients
European Archives of Psychiatry and Clinical Neuroscience, 10/13/09
Relevance Score: 46%
Sodium Load Combined with Low Doses of Exogenous Angiotensin II Upregulate Intrarenal Angiotensin II
Kidney and Blood Pressure Research, 10/08/09
Relevance Score: 46%
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/20/09
Suicide in the Northern Territory, 2001-2006
Australian and New Zealand Journal of Psychiatry, 12/20/09
Is lithium in a class of its own? A brief profile of its clinical use
Australian and New Zealand Journal of Psychiatry, 12/20/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/20/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/20/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor